PNC Financial Services Group’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$358 Buy
2,171
+1,767
+437% +$493 ﹤0.01% 5040
2026
Q1
$133 Buy
404
+205
+103% +$322 ﹤0.01% 5079
2025
Q4
$617 Sell
199
-90
-31% -$257 ﹤0.01% 4793
2025
Q3
$760 Buy
+289
New +$637 ﹤0.01% 4729
2022
Q4
Sell
-9
Closed 4802
2022
Q3
$0 Buy
+9
New +$112 ﹤0.01% 4512
2022
Q1
Sell
-200
Closed -$2K 4593
2021
Q4
$2K Sell
200
-200
-50% -$2.38K ﹤0.01% 4159
2021
Q3
$6K Buy
+400
New +$3.68K ﹤0.01% 3881

Other funds holding GOSS

PNC Financial Services Group's GOSS Position: Q2 2026 in Review

PNC Financial Services Group increased its Gossamer Bio (GOSS) stake by 437% in Q2 2026, buying an estimated $493 and bringing the position to 2,171 shares worth $358. The position accounts for ﹤0.01% of the portfolio, ranked #5040.

PNC Financial Services Group first reported a position in GOSS in Q3 2021 and has held it in 7 quarters since. The position peaked at $6K in Q3 2021. 66 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • PNC Financial Services Group held 2,171 shares of Gossamer Bio worth $358 as of Q2 2026.
  • PNC Financial Services Group bought 1,767 Gossamer Bio shares in Q2 2026, an estimated $493.
  • Gossamer Bio made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #5040 holding.
  • PNC Financial Services Group first reported a position in Gossamer Bio in Q3 2021 and has held it in 7 quarters since.
  • PNC Financial Services Group's Gossamer Bio position peaked at $6K in Q3 2021.
  • 66 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.